Science Outreach-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

A "Head-to-Head" Scientific Comparative Study: YF Cryoprotectant Self-Developed by Yinfeng Life Science Research Institute Demonstrates Significantly Superior Safety and Ice Inhibition Efficacy

Breakthrough Organ Preservation Technology: Achieving Long-Term and Safe Preservation of Cells and Organs

Breaking the Cryopreservation Bottleneck: New Pretreatment Technique Boosts NK Cell Recovery Rate to 90%–100% After Thawing

Scientists Achieve Functional "Revival" of Mouse Brain Tissue After Rewarming from -196°C Freezing First Successful Revival of Frozen Brain! Mouse brain tissue regains memory function after being frozen at -196°C and rewarmed

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

A "Head-to-Head" Scientific Comparative Study: YF Cryoprotectant Self-Developed by Yinfeng Life Science Research Institute Demonstrates Significantly Superior Safety and Ice Inhibition Efficacy

2026/09/09

This head‑to‑head comparative study, backed by solid and transparent data, unequivocally demonstrates that China‑developed cryoprotectants already possess significant international competitiveness in core performance. This not only reflects Yinfeng's technological prowess but also serves as a compelling testament to China's cryobiomedicine field transitioning from "following" to "running alongside" global leaders—earning international discourse power through scientific evidence.

Breakthrough Organ Preservation Technology: Achieving Long-Term and Safe Preservation of Cells and Organs

2026/05/18

Beyond organ transplantation, this non-toxic low-temperature preservation framework can be extended to long-term storage of stem cells, reproductive cells, and germplasm resources of endangered species, providing a universal technological foundation for biobanks, regenerative medicine, and other fields.

Breaking the Cryopreservation Bottleneck: New Pretreatment Technique Boosts NK Cell Recovery Rate to 90%–100% After Thawing

2026/04/29

The clinical value of this approach lies in its extremely simple operation. It requires no specialized cryopreservation solutions or complex equipment, using only GMP‑grade compliant cytokines that can be removed by routine washing after pretreatment, posing no additional safety risks to patients and enabling rapid integration into existing cell production and cryopreservation workflows. As the large‑scale manufacturing of NK cells derived from umbilical cord blood and iPSCs becomes increasingly mature, combining this cryopreservation technology holds the potential to significantly reduce cell therapy costs and improve accessibility, opening new avenues for immunotherapy in hematological malignancies and solid tumors.

Scientists Achieve Functional "Revival" of Mouse Brain Tissue After Rewarming from -196°C Freezing First Successful Revival of Frozen Brain! Mouse brain tissue regains memory function after being frozen at -196°C and rewarmed

2026/03/16

In science fiction, human cryopreservation and resuscitation are often regarded as a "time capsule" to the future. Now, this concept has achieved a milestone breakthrough in the laboratory—scientists have for the first time successfully cryopreserved adult mouse brain slices in liquid nitrogen at -196°C and restored multiple key neural functions, including learning and memory mechanisms, after rewarming. This achievement blazes a brand-new trail for basic neuroscience research and organ preservation technology.

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

2025/08/15

In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

2025/07/03

On June 25, 2025, the team led by Professor Wang Huiying and Dr. Jin Bo from Shenzhen Hospital of Beijing University of Chinese Medicine collaborated with Shandong Yinfeng Life Science Research Institute to develop the "ovarian dual activation" technology. Through this technology, patients with POI (primary ovarian insufficiency) underwent intra - operative freeze - thaw activation of ovarian tissue. After intra - operative transplantation, a baby was born, and both the mother and the baby are healthy and safe.

2026-06-12

→

World’s First “Reverse Aging” Gene Therapy Completes First Human Injection

In addition to eye diseases, Life Biosciences is exploring the potential of “partial reprogramming” for conditions such as liver fibrosis. If this trial confirms its safety and feasibility, it could open an entirely new path for anti-aging medicine—shifting from passively managing age-related diseases to actively reversing the aging process at the cellular level.

2026-06-12

→

Blocking "Xenophagocytosis": A Key Step Toward Growing Human Organs in Animals

Experts in the field believe that this study has found the key to protecting cross-species cells from early immune system clearance, opening a new door for regenerative medicine.

2026-06-05

→

"Cell Robots": Magnetic Remote-Controlled Stem Cells Promote Spinal Cord Regeneration

To move toward clinical application, the team is developing a multi-chip parallel system to boost production capacity, with potential future expansion into areas such as cardiovascular disease, tumor therapy, and wound healing. From spinal cord repair to other hard-to-treat diseases, this technology may bring new hope to countless patients.

2026-06-05

→

World’s First! Chinese Team Successfully Achieves Combined Whole Liver and Dual Kidney Xenotransplantation in a Human

Millions of people worldwide lose their lives each year due to organ shortages. This breakthrough proves that multi‑organ xenotransplantation is feasible in the complex human environment, and the Chinese team is illuminating a new dawn for the organ shortage crisis.

2026-05-29

→

Scientists Develop a 'Molecular Clock' to Predict Mammalian Aging and Lifespan

The road from the laboratory to clinical application is still long. But the advent of this 'molecular clock' has opened a new window for understanding aging and developing targeted longevity strategies. As the researchers themselves put it: 'It not only helps us better understand aging but also brings us one step closer to the goal of healthy aging.'

2026-05-29

→

Milestone in Synthetic Life: First Artificial Cells Reproduce with 'One Mother, Two Different Daughters'

As the researchers put it: "We have not only created 'living' artificial cells, but also taught them to 'reproduce' — and to give birth to two different offspring." This may well be the first step toward true synthetic life.

2026-05-22

→

World First: Breakthrough in Combined Brain-Computer Interface Therapy Enables Late-Stage Paraplegic Patient to Walk Again

From "complete paralysis" to "assisted walking," from "medical dogma" to "clinical reversal," Mr. Wang's small step represents a giant leap for China's brain science and neural repair.

2026-05-22

→

Installing a "Live" Switch for the Heart: Chinese Scientists Achieve Neural Regulation of Heartbeat in a Petri Dish for the First Time

Industry experts believe this achievement represents a critical step forward for China in the fields of cardiac organoids and regenerative medicine, bringing new hope to hundreds of millions of arrhythmia patients worldwide.

2026-05-18

→

Breakthrough Organ Preservation Technology: Achieving Long-Term and Safe Preservation of Cells and Organs